The rising interest in successful weight management has led to considerable exploration into cutting-edge treatments. Recently , Retatrutide, a combined -action glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist , has demonstrated positive results in medical trials, implying potential for substan